Dialysis Market Growth, Demand and Challenges of the Key Industry Players 2023-2028
                     Global Dialysis Market 
Research and Forecast 
Report 2023-2028
Format: PDF+EXCEL
© 2023 IMARC All Rights Reserved 
About IMARC Group
In ternat ional  Market  Analys is  Research and Consul t ing Group is  a leading adv iser  on management  
s t rategy and market  research wor ldwide.  We par tner  wi th c l ients  in  a l l  regions and indust ry  
vert ica ls  to  ident i fy  thei r  h ighest -value oppor tuni t ies,  address thei r  most  cr i t ica l  chal lenges,  and 
t ransform thei r  bus inesses.
IMARC’s in format ion products  inc lude major market ,  sc ient i f ic ,  economic and technological  
developments  for  bus iness leaders  in  pharmaceut ica l ,  indust r ia l ,  and h igh technology 
organizat ions.  Market  forecasts  and indust ry  analys is  for  b iotechnology,  advanced mater ia ls ,  
chemicals ,  food and beverage,  t ravel  and tour ism, nanotechnology and novel  process ing methods 
are at  the top of  the company’s  exper t ise.
IMARC’s ta i lored approach combines unfathomable ins ight  in to the dynamics o f  companies and 
markets wi th c lose cooperat ion at  a l l  levels  of  the c l ient  organizat ion.  This ensures that  our  c l ients 
achieve unmatchable compet i t ive advantage,  bui ld  more pro f ic ient  organizat ions,  and secure 
las t ing resul ts .
Accord ing to  the la tes t  repor t  by  IMARC Group,  t i t led  "Dialysis Market:  
Global  Industry Trends,  Share,  S ize,  Growth,  Opportuni ty  and 
Forecast  2023-2028,"  the g lobal  d ia lys is  market  s ize reached US$ 110.4 
Bi l l ion in  2022.
Report Dia lys is  is  a  t reatment  for  ind iv iduals  w i th  k idney fa i lure  and end-s tage 
renal  d isease (ESRD),  which can be caused by d iabetes,  hyper tension,  
Highlight and and lupus.  I t  inc ludes pur i fy ing the b lood of  a  pat ient ,  restor ing e lec t ro ly te  
ba lance,  and c leans ing the b lood of  harmfu l  substances.  
Description I t  i s  convenient ,  f lex ib le ,  prov ides mobi l i ty ,  and has a bet ter  surv iva l  ra te .  
As a resu l t ,  d ia lys is  is  wide ly  per formed on pat ients  wi th  acute renal  
in jury,  k idney t ransplants ,  and chron ic  k idney d iseases (CKD).
Request  for  a  PDF sample of  th is  report :  
ht tps : / /www. imarcgroup.com/d ia lys is -market / requestsample
Report Description
G lo b a l  D i a ly s i s  M a r k e t  T r e n d s :
T h e  m a r k e t  i s  p r i m a r i l y  d r i v e n  b y  t h e  g r o w i n g  p r e v a l e n c e  o f  c h r o n i c  k i d n e y  d i s e a s e s  ( C K D )  a n d  t h e  i n c r e a s i n g  n u m b e r  o f  p a t i e n t s  
w i t h  h y p e r  b l o o d  p r e s s u r e ,  e n d - s t a g e  r e n a l  d i s e a s e  ( E S R D ) ,  a n d  d i a b e te s .  I n  a d d i t i o n ,  t h e  r i s i n g  d e m a n d  f o r  h e m o d i a l y s i s  f o r  
i m p r o v i n g  h e a l t h  a n d  m i n i m i z i n g  t h e  r i s k  o f  n e r v e  d a m a g e  i s  c o n t r i b u t i n g  t o  t h e  m a r k e t  g r o w t h .  Mo r e o v e r ,  t h e  g r o w i n g  a w a r e n e s s  
r e g a r d i n g  t h e  i m p o r t a n c e  o f  m a i n t a i n i n g  k i d n e y  h e a l t h  a n d  p r o v i d i n g  e a s y  a c c e s s  t o  m u l t i p l e  r e n a l  t r e a t m e n t  o p t i o n s  r e p r e s e n t s  
a n o th e r  ma j o r  g r o w t h - i n d u c i n g  f a c t o r .  
B e s i d e s  t h i s ,  t h e  i n c r e a s i n g  i n c l i n a t i o n  t o w a r d  d i a l y s i s  o v e r  k i d n e y  t r a n s p l a n t  o w i n g  t o  t h e i r  b e n e f i t s ,  s u c h  a s  m i n i m i z e d  h e a l t h  
c o m p l i c a t i o n s  a n d  e n h a n c e d  q u a l i t y  o f  c a r e ,  i s  a c c e l e r a t i n g  t h e  p r o d u c t  a d o p t i o n  r a te .  A l o n g  w i t h  t h i s ,  t h e  i n t r o d u c t i o n  o f  
s o r b e n t - b a s e d  r e g e n e r a t i v e  t e c h n o l o g y  e n a b l i n g  t h e  d e l i v e r y  o f  h i g h - d o s e  d i a l y s i s  w i t h  a  l o w  v o l u m e  o f  d i a l y s i s  s o l u t i o n  w h i l e  
r e m o v i n g  t o x i n s  i s  p r o p e l l i n g  t h e  m a r k e t  g r o w t h .  F u r t h e r mo r e ,  t h e  g r o w i n g  t r e n d  o f  h o m e  d i a l y s i s ,  e s p e c i a l l y  a m o n g  g e r i a t r i c  
p o p u l a t i o n s  w i t h  c h r o n i c  k i d n e y  d y s fu n c t i o n s ,  i n v e s tm e n t  i n  h e a l t h c a r e  i n f r a s t r u c tu r e ,  a n d  e x t e n s i v e  r e s e a r c h  a n d  d e v e l o p m e n t  
( R & D )  a c t i v i t i e s  a n d  c l i n i c a l  t r i a l s  f o r  t r e a t i n g  C K D  a r e  o t h e r  f a c to r s  c r e a t i n g  a  f a v o r a b l e  m a r k e t  o u t l o o k .
L o o k in g  f o r w a r d ,  IM A R C  G r o u p  e x p e c t s  t h e  m a r k e t  v a lu e  t o  r e a c h  U S $  1 4 8 . 8  B i l l i o n  b y  2 0 2 8 ,  e x h i b i t i n g  a  C A G R  o f  4 .9 %  
d u r in g  t h e  f o r e c a s t  p e r i o d  ( 2 0 2 3 - 2 0 2 8 ) .
V ie w  R e p o r t  T O C ,  F i g u r e s  a n d  T a b l e s :  h t t p s : / / w w w . i m a r c g r o u p . c o m / d i a l y s is - m a r k e t
Breakup by Type:
• Hemodialysis
o Conventional  Hemodialys is
o Short Dai ly Hemodialys is
o Nocturnal  Hemodialys is
• Peri toneal  Dia lysis
o Continuous Ambulatory Per i toneal  Dia lys is  
Report (CAPD)
o Automated Per i toneal  Dialys is  (APD)
Segmentation  
Breakup by Product and Services:
• Services
• Equipment
o Dialys is  Machines
o Water Treatment Systems
o Others
• Consumables
o Dialyzers
o Catheters
o Others
• Dialysis  Drugs
Breakup by End User:
Report • In-center Dialysis
• Home Dialysis
Segmentation
Breakup by Region:
• North America
• Asia-Pacifi c
• Europe
• Lat in America
• Middle East  and Afr ica
• Asahi  Kasei  Corporation
• B. Braun Melsungen AG
• Baxter International  Inc.
• Becton Dickinson and Company
Competitive 
• DaVita Inc.
Landscape • Fresenius Medical Care AG & Co. KGaA
with Key • JMS Co. Ltd.
• Medtronic plc
Players
• Nikkiso Co. Ltd.
• NIPRO Corporation
• Satel l i te Healthcare Inc.
• Toray Industries Inc.
What was the size of the global dialysis market in 2022?
What is the expected growth rate of the global dialysis 
market during 2023-2028?
What are the key factors driving the global dialysis 
market?
Key 
What has been the impact of COVID-19 on the global 
Questions dialysis market?
Answered in What is the breakup of the global dialysis market based on type?
the Report What is the breakup of the global dialysis market based on the product and services?
What is the breakup of the global dialysis market based 
on the end user?
What are the key regions in the global dialysis market?
Who are the key players/companies in the global 
dialysis market?
1     P r e f a c e
2     S c o p e  a n d  M e t h o d o l o g y
    2 . 1     O b j e c t i v e s  o f  t h e  S t u d y
    2 . 2     S t a k e h o l d e r s
    2 . 3     D a t a  S o u r c e s
        2 . 3 . 1     P r i m a r y  S o u r c e s
        2 . 3 . 2     S e c o n d a r y  S o u r c e s
    2 . 4     M a r k e t  E s t i m a t i o n
Table of         2 . 4 . 1     B o t t o m - U p  A p p r o a c h        2 . 4 . 2     T o p - D o w n  A p p r o a c h
    2 . 5     F o r e c a s t i n g  M e t h o d o l o g y
3     E x e c u t i v e  S u m m a r y
4     I n t r o d u c t i o n
Contents     4 . 1     O v e r v i e w    4 . 2     K e y  I n d u s t r y  T r e n d s
5     G l o b a l  D i a l y s i s  M a r k e t
    5 . 1     M a r k e t  O v e r v i e w
    5 . 2     M a r k e t  P e r f o r m a n c e
    5 . 3     I m p a c t  o f  C O V I D - 1 9
    5 . 4     M a r k e t  F o r e c a s t
6      M a r k e t  B r e a k u p  b y  T y p e
    6 . 1     H e m o d i a l y s i s
        6 . 1 . 1  M a r k e t  T r e n d s
        6 . 1 . 2  K e y  S e g m e n t s
           6 . 1 . 2 . 1  C o n v e n t i o n a l  H e m o d i a l y s i s
           6 . 1 . 2 . 2  S h o r t  D a i l y  H e m o d i a l y s i s
           6 . 1 . 2 . 3  N o c t u r n a l  H e m o d i a l y s i s
        6 . 1 . 3  M a r k e t  F o r e c a s t
    6 . 2     P e r i t o n e a l  D i a l y s i s
        6 . 2 . 1  M a r k e t  T r e n d s
       
        6 . 2 . 2  K e y  S e g m e n t s
           6 . 2 . 2 . 1  C o n t i n u o u s  A m b u l a t o r y  P e r i t o n e a l  D i a l y s i s  ( C A P D )
           6 . 2 . 2 . 2  A u t o m a t e d  P e r i t o n e a l  D i a l y s i s  ( A P D )
        6 . 2 . 3  M a r k e t  F o r e c a s t
7    M a r k e t  B r e a k u p  b y  P r o d u c t  a n d  S e r v i c e s
    7 . 1     S e r v i c e s
        7 . 1 . 1  M a r k e t  T r e n d s
        7 . 1 . 2  M a r k e t  F o r e c a s t
    7 . 2     E q u i p m e n t
        7 . 2 . 1  M a r k e t  T r e n d s
        7 . 2 . 2  K e y  S e g m e n t s
Table of            7 . 2 . 2 . 1  D i a l y s i s  M a c h i n e s           7 . 2 . 2 . 2  W a t e r  T r e a t m e n t  S y s t e m s
           7 . 2 . 2 . 3  O t h e r s
        7 . 2 . 3  M a r k e t  F o r e c a s t
Contents     7 . 3     C o n s u m a b l e s
        7 . 3 . 1  M a r k e t  T r e n d s
        7 . 3 . 2  K e y  S e g m e n t s
           7 . 3 . 2 . 1  D i a l y z e r s
           7 . 3 . 2 . 2  C a t h e t e r s
           7 . 3 . 2 . 3  O t h e r s
        7 . 3 . 3  M a r k e t  F o r e c a s t
    7 . 4     D i a l y s i s  D r u g s
        7 . 4 . 1  M a r k e t  T r e n d s
        7 . 4 . 2  M a r k e t  F o r e c a s t
8    M a r k e t  B r e a k u p  b y  E n d  U s e r
    8 . 1     I n - c e n t e r  D i a l y s i s
        8 . 1 . 1  M a r k e t  T r e n d s
        8 . 1 . 2  M a r k e t  F o r e c a s t
F o r  m o r e  i n f o r m a t i o n ,  v i s i t :  
ht t ps : / /w ww. i ma rc gro up . c o m /d i a l y s i s -m a rke t / t o c
Disclaimer
© 2023  IMARC Al l  R ights  Reserved 
Th is  Pub l i ca t ion  and  a l l  i t ’ s  con ten ts  un less  o therw ise  men t i oned  a re  copy r i gh ted  in  the  name o f  
I n t e rna t i ona l  Marke t  Ana lys i s  Research  and  Consu l t ing  ( IMARC) .  No  pa r t  o f  t h i s  pub l i ca t ion  may  be  
rep roduced ,  repackaged ,  red i s t r i bu ted  o r  res o ld  i n  who le  o r  i n  any  pa r t .  The  pub l i ca t ion  may  a l so  
no t  be  used  i n  any  f o rm o r  by  and means  g raph i c  e lec t ron ic  o r  mechan ic a l ,  i nc lud ing  pho tocopy ing ,  
reco rd ing ,  t ap ing  o r  by  i n fo rmat i on  s to rage  o r  re t r ieva l ,  o r  by  any  o the r  f o rm,  w i t hou t  the  exp ress  
c ons en t  o f  I n t e rna t iona l  Marke t  Ana lys i s  Research  and  Consu l t i ng  ( IMARC) .
Disc la imer :  Al l  con ten ts  and  da ta  o f  t h i s  pub l i c a t i on ,  i nc lud ing  fo recas t s ,  da ta  ana lys i s  and  op in ion  
have  been  based  on  in f o rmat ion  and  sources  be l ieved  to  be  accu ra te  and  re l iab le  a t  t he  t ime  o f  
pub l i sh ing .  In t e rna t i ona l  Ma rke t  Ana l ys is  Research  and  Consu l t ing  makes  no  rep resen ta t ion  o f  
war ran t y  o f  any  k ind  as  to  t he  acc u racy  o r  comp le teness  o f  any  I n fo rmat i on  p rov ided .  IMARC 
accep ts  no  l i ab i l i t y  wha tsoever  f o r  any  los s  o r  damage  resu l t i ng  f rom op in ion ,  e r ro rs  o r  
i naccu rac ies  i f  any  f ound  th is  pub l i ca t ion .
IMARC,  IMARC Group  and  G loba l  Therapy  I ns igh t  Ser i es  a re  reg is t e red  t rademarks  o f  I n te rna t iona l  
Marke t  Ana lys i s  Research  and  Consu l t ing .  A l l  o the r  t rademarks  used  i n  th i s  pub l i ca t i on  a re  
reg i s te red  t rademarks  o f  t he i r  r espec t i ve  compan ies .
Contact Us
Visit us at :
https://www.imarcgroup.com
TELEPHONE: +1-631-791-1145 
E-MAIL: [email protected]